Sporadic Guam Parkinsonian Complex or the Co-incidence of Several Neurodegenerative Conditions?

Česká verzia

Authors: K. Farníková; P. Kaňovský; I. Nestrašil; P. Otruba
Authors place of work: Neurologická klinika LF UP a FN Olomouc
Published in the journal: Cesk Slov Neurol N 2008; 71/104(3): 342-351
Category: Case Report

Summary

Background:
The parkinsonian complex of Guam is an endemic neurodegenerative condition, which has been described only in the islands of Guam archipelago and at the Kii peninsula of Japan. Up to now, only one „sporadic“ case has been described (including the autopsy) in Japan. Study objective: To describe the clinical, laboratory and neurophysiological characteristics of the neurodegenerative disorder presenting in 4 patients with the complex syndrome of parkinsonism, amyotrophic lateral sclerosis, and dementia.

Patients and Methods:
4 consecutive patients of caucasian and Czech origin, presenting with the complex syndrome of slowly progressive parkinsonism, amyotrophic lateral sclerosis and dementia were completely examined clinically, including neuropsychological examination, and they were assessed using MRI, EMG and EP. The blood and CSF samples were also examined, and the levels of inflammatory and neurodegenerative markers (beta-amyloid, cystatin C and tau-proteins) were established.

Results:
The clinical phenotype in all four patiens was corresponding to that one described in the parkinsonian complex of Guam, including the presence of cognitive deficit at the level of mild to severe dementia. The findings of EMG examination in all cases were those typically seen in ALS, and they met the El Escorial criteria. CSF levels of neurodegenerative markers (tau-protein) were elevated in all four patiens. CSF levels of inflammatory markers were normal.

Conclusion:
The unique appearance of the syndrome typical for the endemic Guam complex in patients of caucasian origin in Europe raises a question of endemicity and heredity of the Guam complex and deserves further rersearch.

Key words:
parkinsonism – dementia – motor neuron disease

Zdroje

1. Steele JC, Caparros-Lefebvre D, Lees AJ, Sacks OW. Progressive supranuclear palsy and its relation to pacific foci of the parkinsonism–dementia complex and Gaudeloupean parkinsonism. Parkinsonism Relat Disord 2002; 9(1): 39–54.

2. Friedlant RP, Armon C. Tales of Pacific tangles. Neurology 2007; 68(21): 1759–1761.

3. Morris HR, Steele JC, Crook R, Wavrant-De Vrieze F, Wood NV, Onstead-Cardinale L et al. Genome-Wide. Analysis of the Parkinsonism-Dementia Complex of Guam. Arch Neurol 2004; 61(12): 1889–1897.

4. Kokubo Y, Kuzuhara S. Neuroradiological Study of Patients with Amyotrophic Lateral Sclerosis and Parkinsonism – Dementia Complex on the Kii Peninsula of Japan. Arch Neurol 2003; 60(9): 1257–1261.

5. Plato CC, Garruto RM, Galasko D, Craig U, Plato M, Gamst A et al. Amyotrophic lateral sclerosis and parkinsonism-dementia complex of Guam: changing incidence rates during the past 60 years. Am J Epidemiol 2003; 157(2): 149–157.

6. Borenstein AR, Mortimer JA, Schofield E, Wu Y, Salmon DP, Gamst A et al. Cycad exposure and risk of dementia, MCI and PDC in the Chamorro population of Guam. Neurology 2007; 68(21): 1764–1771.

7. Forman MS, Schmidt ML, Kasturi S, Perl DP, Lee VM, Trojanowski JQ. Tau and alpha-synuclein pathology in amygdala of Parkinsonism-dementia complex patients of Guam. Am J Pathol 2002; 160(5): 1725–1731.

8. Ince PG, Codd GA. Return of the cycad hypotesis – does the amyotrophic lateral sclerosis/parkinsonism dementia complex (ALS/PDC) of Guam have new implications for global health? Neuropathol Appl Neurobiol 2005; 31(4): 345–353.

9. Cox PA, Banack S, Murch S, Sacks O. Commentary on: Return of the cycad hypotesis – does the amyotrophic lateral sclerosis/Parkinsonism dementia complex (ALS/PDC) of Guam have nex implications for global health? Neuropathol Appl Neurobiol 2006; 32(6): 679–682.

10. Kaňovský P. Parkinsonské syndromy. In: Růžička E, Roth J, Kaňovský P (Eds). Extrapyramidová onemocnění I. Parkinsonova nemoc a parkinsonské syndromy. Praha: Galén 2001.

11. Hughes AJ, Daniel SE, Lees AJ. Idiopathic Parkinson´s disease combined with multiple system atrophy. A clinicopathological report. Mov Disord 1991; 6(4): 342–346.

12. Quinn N. Multiple system atrophy – the nature of the beast. J Neurol Neurosurg Psychiatry 1989; Suppl: 788–789.

13. Kaňovský P, Streitová H, Bareš M, Kuba R, Pospíšilová D. Multisystémová atrofie: nový nosologický koncept. Cesk Slov Neurol N 1996; 59/92(1): 3–9.

14. Dale RC, Churchyard AJ, Surtees RA, Lees AJ, Adcock JE, Gardiny B et al. Encephalitis lethargica syndrome: 20 new cases and evidence of basal ganglia imunity. Brain 2004; 127(Pt 1): 21–33.

15. Uitti R, Calne DB. Pathogenesis of idiopathic parkinsonism. Eur Neurol 1993; 33 Suppl 1: 6–23.

16. Shintaku M, Oyanagi K, Kaneda D. Amyotrophic lateral sclerosis with dementia showing clinical parkinsonism and severe degeneration of the substantia nigra: report of an autopsy case. Neuropathology 2007; 27(3): 295–299.

17. Lees AJ. osobní sdělení 2007.